{"id":835208,"date":"2025-04-08T16:15:56","date_gmt":"2025-04-08T20:15:56","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\/"},"modified":"2025-04-08T16:15:56","modified_gmt":"2025-04-08T20:15:56","slug":"vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\/","title":{"rendered":"Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SAN MATEO, Calif., April  08, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pRSoJS4egi5AoUvSmziXfzPTtM5867S_AYz5wh1jl-8Ed1C7_ZCqcFQS1o-NHlC0BB-egWkIvME-MZkyB4-OdDCBDAlrEzs49Q1A03dXhe0=\" rel=\"nofollow\" target=\"_blank\">Vincerx Pharma, Inc.<\/a> (Nasdaq: VINC) today announced that it has terminated the previously announced non-binding Letter of Intent (LOI) with Global Digital Holdings Inc., conducting business as QumulusAI, regarding a potential merger.<\/p>\n<p>Following this decision, the Company\u2019s board of directors has authorized management to initiate wind-down activities and continue exploring monetization of assets and out-licensing opportunities.<\/p>\n<p>\u201cI want to express our deepest gratitude to the investigators, patients, employees, and partners who have supported Vincerx\u2019s mission,\u201d said Raquel Izumi, Ph.D., Acting Chief Executive Officer of Vincerx. \u201cYour contributions have meant everything. Although unprecedented, adverse market dynamics prevented us from continuing the development of our programs, numerous patients with cancer\u2014who had few therapeutic options\u2014benefited from our therapies in the Phase 1 trials. For the chance you gave us to help those patients, we thank you.\u201d<\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p>This press release contains forward-looking statements within the meaning of U.S. federal securities laws. Forward-looking statements, which are based on certain assumptions and describe future plans, strategies, expectations and events and include, but are not limited to, the Company\u2019s ability to out-licensing or otherwise monetize its assets, intellectual property and technologies and wind-down operations. Forward-looking statements are neither historical facts nor assurances of future performance or events. Instead, they are based only on current beliefs, expectations, and assumptions regarding future business developments, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Forward-looking statements are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict, many of which are outside the Company\u2019s control.<\/p>\n<p>Actual results, conditions, and events may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause actual results, conditions, and events to differ materially from those indicated in the forward-looking statements include, but are not limited to: availability and sufficiency of cash to complete an orderly wind-down of the Company\u2019s business; the Company\u2019s ability to out-license or otherwise monetize its assets and intellectual property and the amount of cash, if any, received from such activities; the Company\u2019s ability to secure stockholder approval to wind down its business; the risk that the Company may need to see protection of the bankruptcy court; and other risks and uncertainties including those set forth in the Company\u2019s Annual Report on Form 10-K for the year ended December 31, 2024 and subsequent reports filed with the Securities and Exchange Commission . Forward-looking statements speak only as of the date hereof, and the Company disclaims any obligation to update any forward-looking statements.<\/p>\n<p>\n        <strong>Contacts:<\/strong>\n      <\/p>\n<p>Gabriela Jairala<br \/>Vincerx Pharma, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XFs2lJh7S655MfWUQEr-QGhMxvgR-3Uc-LVFYexFbBkHYiVBrMh_ixikCVw4RastglenR-4NkeH-rssZVwuYJohhNhMArO2VnoTYRV-8wjqcGWHL6zCc5xMyHnlYJSR-_R59zmXtCK2wCtCvdud4uxBMhFdPdBq0zanRjMMTbgErmzofDjC2L5kKWJEoXEgrdur9C52SS9hgOilqCQDdaJTbTR7ud9uef96t1y5dDHBqU3tpmEcafsp7uidXytti4GMv8hwXy3qB291jCuzxg-wY8erqqzwIAEE1zwrF-4dujqMDD3B9SWLV2HNnZGGI\" rel=\"nofollow\" target=\"_blank\">gabriela.jairala@vincerx.com<\/a><\/p>\n<p>Totyana Simien<br \/>Inizio Evoke Comms<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZuVbMembFHT8nEblWOQxe-Xf-CFuVI3aANUXgRNGOIm-QO_vKWMlFDyYqLHRA-K-0UX2Fe8p07ychxX1VrvtGr3d3-_rhkLI2QPBD8ZlnwqX1yHdMt38C4-jyP1d92u6m6Go8R5zE8yW_Fgs9FQYG8JCHeVuw38gWFHhoxylDJvE5kKOqBLw8-mmxqt1xbGQrc9MPXI6VExJopIOORSXyiYZRpZWP6oIzFNLYeF0t7qw2hnNpgrf9xqtmh_ysaSt0-abBTbDZqjxNb_wsjkZ-hoySOwoOq5ltxjxI9hkd5Ui9rSEhlcSx-hGVfed6YDp\" rel=\"nofollow\" target=\"_blank\">totyana.simien@inizioevoke.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxOTAwNyM2ODU2OTM2IzIyMDM1MjQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/Y2M4ZTAwZGQtZTJkNi00NTlhLWE2ODYtMTZmZjkwMWEwNDE3LTEyMTUwNzctMjAyNS0wNC0wOC1lbg==\/tiny\/Vincerx-Pharma-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN MATEO, Calif., April 08, 2025 (GLOBE NEWSWIRE) &#8212; Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has terminated the previously announced non-binding Letter of Intent (LOI) with Global Digital Holdings Inc., conducting business as QumulusAI, regarding a potential merger. Following this decision, the Company\u2019s board of directors has authorized management to initiate wind-down activities and continue exploring monetization of assets and out-licensing opportunities. \u201cI want to express our deepest gratitude to the investigators, patients, employees, and partners who have supported Vincerx\u2019s mission,\u201d said Raquel Izumi, Ph.D., Acting Chief Executive Officer of Vincerx. \u201cYour contributions have meant everything. Although unprecedented, adverse market dynamics prevented us from continuing the development of our programs, numerous patients with cancer\u2014who had few therapeutic &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-835208","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN MATEO, Calif., April 08, 2025 (GLOBE NEWSWIRE) &#8212; Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has terminated the previously announced non-binding Letter of Intent (LOI) with Global Digital Holdings Inc., conducting business as QumulusAI, regarding a potential merger. Following this decision, the Company\u2019s board of directors has authorized management to initiate wind-down activities and continue exploring monetization of assets and out-licensing opportunities. \u201cI want to express our deepest gratitude to the investigators, patients, employees, and partners who have supported Vincerx\u2019s mission,\u201d said Raquel Izumi, Ph.D., Acting Chief Executive Officer of Vincerx. \u201cYour contributions have meant everything. Although unprecedented, adverse market dynamics prevented us from continuing the development of our programs, numerous patients with cancer\u2014who had few therapeutic &hellip; Continue reading &quot;Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-08T20:15:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxOTAwNyM2ODU2OTM2IzIyMDM1MjQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities\",\"datePublished\":\"2025-04-08T20:15:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\\\/\"},\"wordCount\":475,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxOTAwNyM2ODU2OTM2IzIyMDM1MjQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\\\/\",\"name\":\"Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxOTAwNyM2ODU2OTM2IzIyMDM1MjQ=\",\"datePublished\":\"2025-04-08T20:15:56+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxOTAwNyM2ODU2OTM2IzIyMDM1MjQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxOTAwNyM2ODU2OTM2IzIyMDM1MjQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\/","og_locale":"en_US","og_type":"article","og_title":"Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities - Market Newsdesk","og_description":"SAN MATEO, Calif., April 08, 2025 (GLOBE NEWSWIRE) &#8212; Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has terminated the previously announced non-binding Letter of Intent (LOI) with Global Digital Holdings Inc., conducting business as QumulusAI, regarding a potential merger. Following this decision, the Company\u2019s board of directors has authorized management to initiate wind-down activities and continue exploring monetization of assets and out-licensing opportunities. \u201cI want to express our deepest gratitude to the investigators, patients, employees, and partners who have supported Vincerx\u2019s mission,\u201d said Raquel Izumi, Ph.D., Acting Chief Executive Officer of Vincerx. \u201cYour contributions have meant everything. Although unprecedented, adverse market dynamics prevented us from continuing the development of our programs, numerous patients with cancer\u2014who had few therapeutic &hellip; Continue reading \"Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-08T20:15:56+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxOTAwNyM2ODU2OTM2IzIyMDM1MjQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities","datePublished":"2025-04-08T20:15:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\/"},"wordCount":475,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxOTAwNyM2ODU2OTM2IzIyMDM1MjQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\/","name":"Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxOTAwNyM2ODU2OTM2IzIyMDM1MjQ=","datePublished":"2025-04-08T20:15:56+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxOTAwNyM2ODU2OTM2IzIyMDM1MjQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxOTAwNyM2ODU2OTM2IzIyMDM1MjQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-authorization-to-pursue-wind-down-activities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/835208","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=835208"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/835208\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=835208"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=835208"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=835208"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}